Literature DB >> 11536053

Isolation of the TSLL1 and TSLL2 genes, members of the tumor suppressor TSLC1 gene family encoding transmembrane proteins.

H Fukuhara1, M Kuramochi, T Nobukuni, T Fukami, M Saino, T Maruyama, S Nomura, T Sekiya, Y Murakami.   

Abstract

We have recently identified the TSLC1 gene as a novel tumor suppressor in human non-small cell lung cancers. TSLC1 encodes a membrane glycoprotein with an extracellular domain homologous to those of immunoglobulin superfamily proteins. Truncation of TSLC1 in the cytoplasmic domain in a primary human tumor suggests that this domain is important for tumor suppressor activity. Here, we report the isolation of two TSLC1-like genes, TSLL1 and TSLL2, based on their structural homology with the sequences corresponding to the cytoplasmic domain of TSLC1. Significant similarity was also observed in the extracellular domain as well as in the overall gene structure, indicating that these three genes form a unique subfamily (the TSLC1-gene family) in the immunoglobulin superfamily genes. In contrast to the ubiquitous expression of TSLC1, TSLL1 is expressed exclusively in adult and fetal human brain, while TSLL2 is expressed in several specific tissues including prostate, brain, kidney and some other organs. Expression of TSLL1 and TSLL2 was lost or markedly reduced in many human glioma cell lines or some prostate cancer cell lines, suggesting that loss of expression of these genes might be involved in some human cancers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11536053     DOI: 10.1038/sj.onc.1204696

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  16 in total

1.  A molecular-properties-based approach to understanding PDZ domain proteins and PDZ ligands.

Authors:  Cosmas Giallourakis; Zhifang Cao; Todd Green; Heather Wachtel; Xiaohui Xie; Marco Lopez-Illasaca; Mark Daly; John Rioux; Ramnik Xavier
Journal:  Genome Res       Date:  2006-07-06       Impact factor: 9.043

2.  SynCAM, a novel putative tumor suppressor, suppresses growth and invasiveness of glioblastoma.

Authors:  Xiaoju Zhang; Wei Li; Yi Kang; Jianguo Zhang; Huijuan Yuan
Journal:  Mol Biol Rep       Date:  2013-08-02       Impact factor: 2.316

3.  Hypoexpression and epigenetic regulation of candidate tumor suppressor gene CADM-2 in human prostate cancer.

Authors:  Guimin Chang; Shuping Xu; Rajiv Dhir; Uma Chandran; Denise S O'Keefe; Norman M Greenberg; Jeffrey R Gingrich
Journal:  Clin Cancer Res       Date:  2010-11-09       Impact factor: 12.531

4.  Overlapping morphological, immunohistochemical and genetic features of superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor.

Authors:  Florian Puls; Jodi M Carter; Nischalan Pillay; Thomas A McCulloch; Vaiyapuri P Sumathi; Pehr Rissler; Henrik Fagman; Magnus Hansson; Fernanda Amary; Roberto Tirabosco; Linda Magnusson; Jenny Nilsson; Adrienne M Flanagan; Andrew L Folpe; Fredrik Mertens
Journal:  Mod Pathol       Date:  2021-12-30       Impact factor: 7.842

5.  Generation of a monoclonal antibody specific to a new candidate tumor suppressor, cell adhesion molecule 2.

Authors:  Meijin Huang; Ziyuan Xia; Yang Wang; Liang Huang; Qian Ma; Xia Chen; Hao Wang; Bin Lu; Yajun Guo
Journal:  Tumour Biol       Date:  2014-04-30

6.  Disruption of Nectin-like 1 cell adhesion molecule leads to delayed axonal myelination in the CNS.

Authors:  Jinsil Park; Ben Liu; Tao Chen; Hong Li; Xuemei Hu; Jing Gao; Ying Zhu; Qiang Zhu; Boqin Qiang; Jiangang Yuan; Xiaozhong Peng; Mengsheng Qiu
Journal:  J Neurosci       Date:  2008-11-26       Impact factor: 6.167

7.  Nectin-like proteins mediate axon Schwann cell interactions along the internode and are essential for myelination.

Authors:  Patrice Maurel; Steven Einheber; Jolanta Galinska; Pratik Thaker; Isabel Lam; Marina B Rubin; Steven S Scherer; Yoshinuri Murakami; David H Gutmann; James L Salzer
Journal:  J Cell Biol       Date:  2007-08-27       Impact factor: 10.539

8.  The Cell Adhesion Molecule Necl-4/CADM4 Serves as a Novel Regulator for Contact Inhibition of Cell Movement and Proliferation.

Authors:  Shota Yamana; Amina Tokiyama; Kiyohito Mizutani; Ken-ichi Hirata; Yoshimi Takai; Yoshiyuki Rikitake
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

9.  Cross-platform analysis of cancer biomarkers: a Bayesian network approach to incorporating mass spectrometry and microarray data.

Authors:  Xutao Deng; Huimin Geng; Hesham H Ali
Journal:  Cancer Inform       Date:  2007-04-29

10.  Putting the glue in glia: Necls mediate Schwann cell axon adhesion.

Authors:  Julie R Perlin; William S Talbot
Journal:  J Cell Biol       Date:  2007-08-27       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.